1: 4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl-4',4',5',5'-tetramethyl-1,3,2-dioxaborolane With [(diglyme)NiBr2]; 2-methyl-propan-1-ol; potassium tert-butylate; Ru(4,4′,4''-tri-t-butyl-2,2′;6,2″-terpyridine)Cl3 in di-isopropyl ether 0.0833333 h; Inert atmosphereCooling with ice; 2: cycloheptyl bromide in di-isopropyl ether T=60°C; 24 h; Inert atmosphere;

[RhCl(cod)]2; Xantphos in tetrahydrofuran 115°, 24 h, cycloheptene (1.2 equiv.), (RhCl(cod))2 (1.3 molpercent), Xantphos (2.5 molpercent); column purifn.; 1H NMR;

[RuH2(η2-H2)2(PCy3)2] in tetrahydrofuran (Ar); Schlenk technique; mixt. of pinacolborane (100 equiv.) and alkene (100 to 1000 equiv.) was added to soln. of Ru catalyst (1 equiv.) in THF; stirred at room temp.; GC monitoring; solvent removed (vac.); distd. (Kugelroehr);